TRAD CHI MED released its interim results, with a loss attributable to shareholders of 108 million yuan, turning from profit to loss year-on-year

TRAD CHI MED released its interim results for the period ending June 30, 2025, with a revenue of 7.463 billion yuan, a year-on-year decrease of 11%. The company's loss attributable to shareholders was 108 million yuan, compared to a profit of 211 million yuan in the same period last year, with a basic loss per share of 2.14 cents. The decline in revenue was mainly due to the increased proportion of traditional Chinese medicine formula granules in the centralized procurement business and intensified market competition. At the same time, the group optimized its business structure, reducing low-margin and high-risk operations, leading to a decrease in sales revenue